Determination of Drug Binding to Plasma Proteins Using Competitive Equilibrium Binding to Dextran-Coated Charcoal

A method for determination of drug binding to plasma proteins, which is based on the comparison of drug affinities to plasma proteins and dextran-coated charcoal, is described. The method is free of nonspecific binding feature. The fractions unbound obtained by the charcoal method are in good agreement with values from a traditional ultrafiltration method for various low and highly bound compounds. The method presently requires drug concentrations much less than that of plasma proteins. A possibility of using the method to determine protein binding at an arbitrary drug concentration is discussed. A mechanism of nonspecific binding of drug to ultrafiltration membranes, which yields a good agreement with experimental observations, is suggested.

[1]  C. Kohlsdorfer,et al.  High-throughput determination of the free fraction of drugs strongly bound to plasma proteins. , 2004, Journal of pharmaceutical sciences.

[2]  B. Madsen,et al.  Kinetic approach to drug-protein binding. , 1974, Journal of pharmaceutical sciences.

[3]  J. Birkmeier,et al.  Determination of protein binding byin vitro charcoal adsorption , 1995, Journal of Pharmacokinetics and Biopharmaceutics.

[4]  W. Jusko,et al.  Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. , 1984, Journal of pharmaceutical sciences.

[5]  R. Gupta,et al.  Binding of centchroman with human serum as determined by charcoal adsorption method. , 1999, International journal of pharmaceutics.

[6]  Younggil Kwon,et al.  Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists , 2001, Springer US.

[7]  M. Ramanathan,et al.  A Rapid Spectrofluorimetric Technique for Determining Drug-Serum Protein Binding Suitable for High-Throughput Screening , 2000, Pharmaceutical Research.

[8]  D G Myszka,et al.  High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE. , 2001, Analytical biochemistry.

[9]  Evon M. O. Abu-Taieh,et al.  Comparative Study , 2020, Definitions.

[10]  O. Borgå,et al.  Serum Protein Binding of Nonsteroidal Antiinflammatory Drugs: A Comparative Study , 1997, Journal of Pharmacokinetics and Biopharmaceutics.

[11]  J. A. Johnson,et al.  Equilibrium and kinetic properties of the Evans blue-albumin system. , 1969, The American journal of physiology.

[12]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[13]  D. Guttman,et al.  Dynamic dialysis as a method for studying protein binding. II. Evaluation of the method with a number of binding systems. , 1970, Journal of pharmaceutical sciences.

[14]  David G Myszka,et al.  Characterizing a drug's primary binding site on albumin. , 2003, Journal of pharmaceutical sciences.